Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
Sales 2017 | 35.9M 38.63M | Sales 2018 | 41.5M 44.65M | Capitalization | 56.19M 60.47M |
---|---|---|---|---|---|
Net income 2017 | 4M 4.3M | Net income 2018 | 3M 3.23M | EV / Sales 2017 | 1.85 x |
Net Debt 2017 | 5.9M 6.34M | Net Debt 2018 | 10.55M 11.35M | EV / Sales 2018 | 1.61 x |
P/E ratio 2017 |
14.7
x | P/E ratio 2018 |
14.1
x | Employees | - |
Yield 2017 |
1.11% | Yield 2018 |
1.98% | Free-Float | 20.71% |
Managers | Title | Age | Since |
---|---|---|---|
Vanni Benedetti
CEO | Chief Executive Officer | 55 | 86-01-01 |
Luca Sforazzini
BRD | Director/Board Member | 49 | 11-01-09 |
Roberto Nisica
BRD | Director/Board Member | 59 | 10-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vanni Benedetti
CEO | Chief Executive Officer | 55 | 86-01-01 |
Roberto Nisica
BRD | Director/Board Member | 59 | 10-05-02 |
Enrico Russo
BRD | Director/Board Member | 38 | 09-12-31 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 80.72M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- BIO2 Stock